The World Health Organisation (WHO) has confirmed an outbreak of Sudan virus disease in Uganda, which is part of the Ebola virus family.

WHO, in a statement, stated that health authorities in Kampala confirmed that one patient had died – a nurse who had sought treatment at various other medical facilities after developing fever-like symptoms.

In response to the outbreak of the often deadly and infectious haemorrhagic fever transmitted through contact with bodily fluids and tissue, WHO is mobilising efforts to support national health authorities in swiftly containing and ending the outbreak.

Senior public health experts and staff from WHO’s country office are being deployed to support key outbreak response measures.

Additionally, WHO has allocated $1 million from its Contingency Fund for emergencies to accelerate early action.

Medical supplies, including personal protective equipment, are being readied for delivery from WHO’s Emergency Response Hub in Nairobi.

Although there are no licensed vaccines for Sudan virus disease, WHO is coordinating with developers to deploy candidate vaccines once all necessary approvals are obtained.

Regarding the deceased man, no other health workers or patients have shown symptoms, said WHO.

A total of 45 contacts, including health workers and family members, are under close monitoring.

The identification of the case in a densely populated urban area necessitates a rapid and intense response, the agency stressed.

Dr Matshidiso Moeti, WHO regional director for Africa, welcomed the prompt outbreak declaration, saying the agency was supporting the government and partners “to scale up measures to quickly identify cases, isolate and provide care, curb the spread of the virus, and protect the population.

“Uganda’s robust expertise in responding to public health emergencies will be crucial in ending this outbreak effectively,” he said. 

There have been eight previous outbreaks of Sudan Ebola Virus Disease, with five in Uganda and three in Sudan.

Uganda last reported an outbreak in 2022. 

 (NAN)